1 active trials 1 recruiting 1 Phase 3 1 disease areas
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05738694 | Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal… | Renal Cell Carcinoma | Recruiting | 2026-03-17 |
Kidney Cancer (1)